The MarketWatch News Department was not involved in the creation of this content. TORONTO, March 5, 2026 /CNW/ - A Women's Work (AWW Org) today announced the launch of the MODWORKS Program: 2026 ...

In the world, where India ranks second when it comes to obesity, the skinny jab has become the most sought-after way to lose weight. From Hollywood red carpets to the pharmacies of South Delhi and ...

Novo Nordisk and its Chinese partner have reported up to 19.7% weight loss in patients who took their triple agonist for 24 weeks, illuminating a potential path forward for the Danish drugmaker as it ...

A new study explores how the extreme biology of pythons may point to an unexpected path for obesity research. Pythons don’t ...

A doctor has issued a stark warning to anyone considering weight loss injections about the "most common" side effect he sees in patients. The expert described it as "absolutely miserable". These ...

A doctor issued a warning to anyone “considering” using weight loss jabs about the “most common” side effect he sees in patients. According to the expert, this can be “absolutely miserable”. These ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Discovering the best protein bars for Weight Watchers can be a game-changer in your weight loss journey. These convenient, nutritious snacks are not just a quick bite but a strategic tool for wisely ...

The new platform lets employers offer GLP-1 drugs like Zepbound at a discounted rate while choosing from a marketplace of administrators. GLP-1 weight-loss drugs have quickly become some of the most ...